Results 41 to 50 of about 13,860 (111)

Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells

open access: yesFrontiers in Immunology, 2020
Neuroblastoma (NB) is the most common extracranial solid tumor in children and, in the high-risk group, has a 5-year mortality rate of ~50%. The high mortality rate and significant treatment-related morbidities associated with current standard of care ...
Kevin O. McNerney   +4 more
doaj   +1 more source

Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting

open access: yesExperimental Hematology & Oncology
Over the past few years, dual-targeted chimeric antigen receptor (CAR) T-cell therapy has been employed in the management of hematological malignancies to mitigate treatment failure, particularly in cases of antigen escape.
Jingyi Yang   +4 more
doaj   +1 more source

Development of Unconventional T Cells Controlled by MicroRNA

open access: yesFrontiers in Immunology, 2019
Post-transcriptional gene regulation through microRNA (miRNA) has emerged as a major control mechanism of multiple biological processes, including development and function of T cells. T cells are vital components of the immune system, with conventional T
Samantha J. Winter, Andreas Krueger
doaj   +1 more source

Role of CD1d- and MR1-Restricted T Cells in Asthma

open access: yesFrontiers in Immunology, 2018
Innate T lymphocytes are a group of relatively recently identified T cells that are not involved in either innate or adaptive immunity. Unlike conventional T cells, most innate T lymphocytes express invariant T cell receptor to recognize exogenous non ...
Chiaki Iwamura, Toshinori Nakayama
doaj   +1 more source

TCR signal strength controls thymic differentiation of iNKT cell subsets

open access: yesNature Communications, 2018
Invariant natural killer T (iNKT) cells can be subsetted by their cytokine profiles, but how they develop in the thymus is unclear. Here the authors show, by analysing mice carrying mutant Zap70 genes, that T cell receptor signaling strength induces ...
Kathryn D. Tuttle   +15 more
doaj   +1 more source

Generation of Human iNKT Cell Lines

open access: yesBio-Protocol, 2013
Natural killer T (NKT) cells comprise an important immunoregulatory T cell subset and express cell surface proteins characteristic of both natural killer cells and T cells.
Xiangming Li   +3 more
doaj   +1 more source

Breakthrough for Anticancer Immunotherapy: Current Advances in Manufacturing Protocols of Chimeric Antigen Receptor-Based Therapies

open access: yesAntibodies
Chimeric antigen receptor (CAR)-based immunotherapy has emerged as a transformative strategy in anticancer treatment, driven by advances in CAR construct design, manufacturing platforms, and expansion to diverse immune cell types. The landmark success of
Yuxin Qian, Weiwei Ma, Xiao-Ning Xu
doaj   +1 more source

How Lipid-Specific T Cells Become Effectors: The Differentiation of iNKT Subsets

open access: yesFrontiers in Immunology, 2018
In contrast to peptide-recognizing T cells, invariant natural killer T (iNKT) cells express a semi-invariant T cell receptor that specifically recognizes self- or foreign-lipids presented by CD1d molecules.
Haiguang Wang, Kristin A. Hogquist
doaj   +1 more source

High Activation of γδ T Cells and the γδ2pos T-Cell Subset Is Associated With the Onset of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome, ANRS 12153 CAPRI NK

open access: yesFrontiers in Immunology, 2019
Background: Human Immunodeficiency Virus 1 (HIV-1) and Mycobacterium Tuberculosis (Mtb) co-infected patients are commonly at risk of immune reconstitution inflammatory syndrome (IRIS) when initiating antiretroviral treatment (ART).
Polidy Pean   +11 more
doaj   +1 more source

Regulation of the terminal maturation of iNKT cells by mediator complex subunit 23

open access: yesNature Communications, 2018
Invariant Natural Killer T cells (iNKT) rapidly exert effector functions upon activation, but the mechanisms of their functional maturation remain to be determined.
Yu Xu   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy